UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000005388
Receipt number R000006397
Scientific Title Randomized Phase II trial of Neoadjuvant weekly Nab-paclitaxel followed by FEC compared with Docetaxel followed by FEC for early breast cancer
Date of disclosure of the study information 2011/06/01
Last modified on 2021/04/27 15:22:28

No. Disposal Last modified on Item of update
1 Insert 2011/04/06 15:54:33
2 Update 2011/07/19 14:02:59 Acronym
3 Update 2011/07/20 09:55:48 Acronym
4 Update 2012/04/09 17:07:17 Post marketing survey by drug manufacture etc., specified by Japanese law.
Institutions
5 Update 2012/11/12 15:57:58 Organization2
Address2
Tel2
Email2
6 Update 2013/04/11 13:13:35 Last name of contact person
Last name of contact person
Institutions
7 Update 2014/04/07 16:40:33 Email
Email
Institutions
8 Update 2014/04/07 16:43:09 Recruitment status
9 Update 2016/04/08 10:37:28 Name of primary person or sponsor
Organization
Tel2
10 Update 2020/04/16 11:45:17 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Organization
Organization
Division name
Division name
Zip code
TEL

Last name of contact person

Last name of contact person
Organization
Organization
Division name
Division name
Zip code
TEL
Email
Organization
Organization
Division name
Division name
Name of primary person or sponsor
Institute
Institute
Department
Organization2
Organization
Organization
Address
Address
Tel
Email
11 Update 2021/04/27 15:22:29 TEL

Last name of contact person

Last name of contact person
TEL
Email
Email2